Naringenin is a Potential Immunomodulator for Inhibiting Liver Fibrosis by Inhibiting the cGAS-STING PathwayLi Chen(Northwestern University)Journal of Clinical and Translational HepatologyApril 28, 202210.14218/jcth.2022.00120Cited by 23SaveCiteExport RISWatch citationsRelated PapersMic19 depletion impairs endoplasmic reticulum-mitochondrial contacts and mitochondrial lipid metabolism and triggers liver disease|Nature Communications|2024|84Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tract|EBioMedicine|2023|22